Apart from BLCA, these negative immunological correlations of Siglec15 were not observed with other malignancies, such as NSCLC, ovarian cancer, melanoma, BRCA, and colorectal cancer. This evidence concerns the gene SIGLEC15 and bladder transitional cell carcinoma.